E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/23/2011 in the Prospect News Investment Grade Daily.

S&P rates McKesson notes A-

Standard & Poor's said it assigned an A- issue-level rating to McKesson Corp.'s (A-/Stable/A-2) proposed senior notes offering.

McKesson will issue three tranches of new notes that will mature in 2016, 2021 and 2041, S&P said, S&P said. The notes will rank equally with the company's existing and future unsecured and unsubordinated debt.

Proceeds will be used for general corporate purposes, including the repayment of borrowings under its senior bridge term loan agreement. McKessson used the bridge loan to partially fund its redemption of debt assumed in the acquisition of U.S. Oncology Holdings Inc. on Dec. 30 for an aggregate consideration of $2.16 billion.

The ratings on McKesson reflect the company's important positions in the pharmaceutical distribution and health care information technology industries as well as the company's long-standing relationships, strong cash flows and modest financial risk profile, the agency said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.